Covista Reports Strong Q3 Growth and Raises Revenue Guidance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 06 2024
0mins
Should l Buy CVSA?
Source: Benzinga
Covista Inc's stock surged by 10.28% as it crossed above the 5-day SMA, reflecting strong investor confidence following its impressive Q3 performance.
The company reported a 4.5% year-over-year revenue increase to $487 million, exceeding market estimates by $13.01 million, and raised its fiscal year 2026 revenue guidance to a range of $1.93 billion to $1.945 billion, anticipating 8% to 9% growth. This positive outlook, along with a significant increase in student enrollment to 100,585, indicates robust demand and effective operational strategies.
Covista's strong quarterly results and optimistic future guidance suggest a solid growth trajectory, enhancing investor confidence and positioning the company favorably in the education sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CVSA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CVSA
Wall Street analysts forecast CVSA stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 117.000
Low
Averages
High
Current: 117.000
Low
Averages
High
About CVSA
Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Covista Reports Strong Quarterly Results and Raises Annual Guidance
- Student Enrollment Growth: Covista's total student enrollment reached 100,585 for the quarter, reflecting a 6.8% year-over-year increase, surpassing expectations and indicating the effectiveness of the company's operational model, with Q4 expected to maintain this growth momentum into the fall enrollment cycle.
- Revenue Guidance Increase: The company raised its FY26 revenue guidance from a range of $1.9 billion to $1.94 billion to a new range of $1.93 billion to $1.945 billion, projecting nearly 8% to 9% year-over-year growth, reflecting optimistic expectations for future market demand.
- Adjusted EPS Improvement: Covista increased its adjusted earnings per share guidance from a previous range of $7.80 to $8.00 to a new range of $7.95 to $8.15, demonstrating enhanced profitability and boosting investor confidence.
- Q3 Performance Exceeds Expectations: The company reported third-quarter revenue of $487 million, a 4.5% year-over-year increase, beating market estimates by $13.01 million, with adjusted EPS of $1.98 exceeding consensus by $0.26, showcasing strong performance in a competitive education market.
See More
Covista Q3 Earnings: Rebranding and Growth Insights
- Strong Performance: Covista reported a 4.5% year-over-year revenue increase to $487 million in Q3, with an adjusted growth of 8.4% when excluding academic calendar shifts, highlighting robust demand and adaptability in the healthcare sector.
- Enrollment Milestone: The company surpassed 100,000 registered students, with Walden achieving a 12.3% increase to over 54,000 students, indicating the effectiveness of its educational model and growing market appeal.
- Guidance Upgrade: CFO Phelan raised full-year revenue guidance to a range of $1.93 billion to $1.945 billion and adjusted EPS guidance to $7.95 to $8.15, reflecting strong confidence in future growth prospects.
- Ongoing Strategic Investments: The company plans to continue strategic investments in Q4, including the development of six new campuses and a new brand campaign, aimed at further enhancing market share and brand influence.
See More
Covista Reports Significant Growth in Q3 Performance
- Total Enrollment Growth: Covista's total student enrollment reached 100,585, marking a 6.8% year-over-year increase, with both Chamberlain and Walden universities achieving record highs, indicating strong momentum in the higher education sector.
- Significant Revenue Increase: The company reported third-quarter revenue of $487 million, up 4.5% year-over-year, and an 8.4% increase when adjusted for Walden's one-week academic shift, reflecting robust performance and improved profitability in the education market.
- Optimized Capital Allocation: In the third quarter, Covista repurchased $66 million in shares and successfully refinanced its debt into a $510 million Term Loan B, extending maturity to 2033, resulting in a net leverage ratio of 0.7x, enhancing financial flexibility.
- Positive Future Outlook: Covista raised its fiscal year 2026 revenue guidance to $1.93 billion to $1.945 billion, anticipating 8% to 9% year-over-year growth, while also increasing adjusted earnings per share expectations to $7.95 to $8.15, demonstrating confidence in future growth prospects.
See More
Covista Launches Healthcare AI Credentials and Future Classroom Development
- Healthcare AI Credentials Live: Covista's healthcare AI credentials, launched in collaboration with Google Cloud, are now available across five institutions, attracting over 3,400 students in the first week, indicating a strong demand for AI fluency in the healthcare sector, which is expected to enhance graduates' competitiveness in the job market.
- Future Classroom Development: Covista is developing an AI-powered future classroom aimed at enhancing educational quality through personalized learning experiences, integrating tools like LearnLM, Gemini, and NotebookLM, with a pilot expected later this year to transform educational methodologies.
- Advisory Council of Industry Leaders: Covista has established the Healthcare AI Readiness Council, bringing together healthcare executives and technology innovators to guide curriculum design, ensuring that AI innovations are closely aligned with clinical practice, thereby producing graduates equipped with essential AI skills.
- Flexible Curriculum Design: The newly launched AI certificate programs are accessible not only to current students but also to alumni and healthcare professionals, with flexible coursework tailored to the schedules of working clinicians, helping them master AI applications in clinical settings to improve patient care quality.
See More
Insider Buying Analysis: Alpha Metallurgical and Covista
- Insider Trading Activity: Director Kenneth S. Courtis of Alpha Metallurgical Resources purchased 25,000 shares of AMR on Monday at $176.23 each, totaling an investment of $4.41 million, indicating confidence in the company's future performance.
- Return on Investment: At today's trading high, Courtis's investment saw an 11.9% return, with AMR reaching a peak price of $197.21, reflecting a positive market response to the stock.
- Historical Purchase Record: Over the past 12 months, Courtis has made four additional purchases of AMR shares, totaling $30.74 million at an average cost of $161.79 per share, demonstrating his sustained optimism about the company's long-term prospects.
- Covista Trading Activity: Director Michael W. Malafronte of Covista bought 36,036 shares on Wednesday at $100.88 each, amounting to a total investment of $3.64 million, with the stock currently up 0.8%, indicating market approval of his investment.
See More
Uplift Appoints New Chief Strategy Officer
- Executive Appointment: Uplift has appointed Evan Trent as Chief Strategy Officer, who will lead the firm's M&A and Integration Value Creation Center from Chicago, expected to enhance the value creation capabilities of portfolio companies through strategic M&A and transformation initiatives.
- Extensive Experience: With over 25 years in the industry, Trent has held multiple senior leadership roles at Covista, where he successfully led major acquisitions and business transformations, providing Uplift with valuable expertise and practical insights for strategic deployment.
- Investment Strategy: Uplift's investment strategy is built on a unique '5-5-5 Framework' targeting companies across five business models and five service sectors, aiming to achieve sustainable value creation through optimized organizational design and go-to-market strategies.
- Market Expansion: Trent's appointment is seen as a significant step for Uplift at this formative stage of growth, with Managing Partner Brad Skaf noting that Trent's experience will aid in institutionalizing and scaling the firm's approach to value creation, thereby enhancing its competitive position in the market.
See More
Covista Reports Strong Quarterly Results and Raises Annual Guidance
- Student Enrollment Growth: Covista's total student enrollment reached 100,585 for the quarter, reflecting a 6.8% year-over-year increase, surpassing expectations and indicating the effectiveness of the company's operational model, with Q4 expected to maintain this growth momentum into the fall enrollment cycle.
- Revenue Guidance Increase: The company raised its FY26 revenue guidance from a range of $1.9 billion to $1.94 billion to a new range of $1.93 billion to $1.945 billion, projecting nearly 8% to 9% year-over-year growth, reflecting optimistic expectations for future market demand.
- Adjusted EPS Improvement: Covista increased its adjusted earnings per share guidance from a previous range of $7.80 to $8.00 to a new range of $7.95 to $8.15, demonstrating enhanced profitability and boosting investor confidence.
- Q3 Performance Exceeds Expectations: The company reported third-quarter revenue of $487 million, a 4.5% year-over-year increase, beating market estimates by $13.01 million, with adjusted EPS of $1.98 exceeding consensus by $0.26, showcasing strong performance in a competitive education market.
See More
Covista Q3 Earnings: Rebranding and Growth Insights
- Strong Performance: Covista reported a 4.5% year-over-year revenue increase to $487 million in Q3, with an adjusted growth of 8.4% when excluding academic calendar shifts, highlighting robust demand and adaptability in the healthcare sector.
- Enrollment Milestone: The company surpassed 100,000 registered students, with Walden achieving a 12.3% increase to over 54,000 students, indicating the effectiveness of its educational model and growing market appeal.
- Guidance Upgrade: CFO Phelan raised full-year revenue guidance to a range of $1.93 billion to $1.945 billion and adjusted EPS guidance to $7.95 to $8.15, reflecting strong confidence in future growth prospects.
- Ongoing Strategic Investments: The company plans to continue strategic investments in Q4, including the development of six new campuses and a new brand campaign, aimed at further enhancing market share and brand influence.
See More
Covista Reports Significant Growth in Q3 Performance
- Total Enrollment Growth: Covista's total student enrollment reached 100,585, marking a 6.8% year-over-year increase, with both Chamberlain and Walden universities achieving record highs, indicating strong momentum in the higher education sector.
- Significant Revenue Increase: The company reported third-quarter revenue of $487 million, up 4.5% year-over-year, and an 8.4% increase when adjusted for Walden's one-week academic shift, reflecting robust performance and improved profitability in the education market.
- Optimized Capital Allocation: In the third quarter, Covista repurchased $66 million in shares and successfully refinanced its debt into a $510 million Term Loan B, extending maturity to 2033, resulting in a net leverage ratio of 0.7x, enhancing financial flexibility.
- Positive Future Outlook: Covista raised its fiscal year 2026 revenue guidance to $1.93 billion to $1.945 billion, anticipating 8% to 9% year-over-year growth, while also increasing adjusted earnings per share expectations to $7.95 to $8.15, demonstrating confidence in future growth prospects.
See More
Covista Launches Healthcare AI Credentials and Future Classroom Development
- Healthcare AI Credentials Live: Covista's healthcare AI credentials, launched in collaboration with Google Cloud, are now available across five institutions, attracting over 3,400 students in the first week, indicating a strong demand for AI fluency in the healthcare sector, which is expected to enhance graduates' competitiveness in the job market.
- Future Classroom Development: Covista is developing an AI-powered future classroom aimed at enhancing educational quality through personalized learning experiences, integrating tools like LearnLM, Gemini, and NotebookLM, with a pilot expected later this year to transform educational methodologies.
- Advisory Council of Industry Leaders: Covista has established the Healthcare AI Readiness Council, bringing together healthcare executives and technology innovators to guide curriculum design, ensuring that AI innovations are closely aligned with clinical practice, thereby producing graduates equipped with essential AI skills.
- Flexible Curriculum Design: The newly launched AI certificate programs are accessible not only to current students but also to alumni and healthcare professionals, with flexible coursework tailored to the schedules of working clinicians, helping them master AI applications in clinical settings to improve patient care quality.
See More
Insider Buying Analysis: Alpha Metallurgical and Covista
- Insider Trading Activity: Director Kenneth S. Courtis of Alpha Metallurgical Resources purchased 25,000 shares of AMR on Monday at $176.23 each, totaling an investment of $4.41 million, indicating confidence in the company's future performance.
- Return on Investment: At today's trading high, Courtis's investment saw an 11.9% return, with AMR reaching a peak price of $197.21, reflecting a positive market response to the stock.
- Historical Purchase Record: Over the past 12 months, Courtis has made four additional purchases of AMR shares, totaling $30.74 million at an average cost of $161.79 per share, demonstrating his sustained optimism about the company's long-term prospects.
- Covista Trading Activity: Director Michael W. Malafronte of Covista bought 36,036 shares on Wednesday at $100.88 each, amounting to a total investment of $3.64 million, with the stock currently up 0.8%, indicating market approval of his investment.
See More
Uplift Appoints New Chief Strategy Officer
- Executive Appointment: Uplift has appointed Evan Trent as Chief Strategy Officer, who will lead the firm's M&A and Integration Value Creation Center from Chicago, expected to enhance the value creation capabilities of portfolio companies through strategic M&A and transformation initiatives.
- Extensive Experience: With over 25 years in the industry, Trent has held multiple senior leadership roles at Covista, where he successfully led major acquisitions and business transformations, providing Uplift with valuable expertise and practical insights for strategic deployment.
- Investment Strategy: Uplift's investment strategy is built on a unique '5-5-5 Framework' targeting companies across five business models and five service sectors, aiming to achieve sustainable value creation through optimized organizational design and go-to-market strategies.
- Market Expansion: Trent's appointment is seen as a significant step for Uplift at this formative stage of growth, with Managing Partner Brad Skaf noting that Trent's experience will aid in institutionalizing and scaling the firm's approach to value creation, thereby enhancing its competitive position in the market.
See More
